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Abstract: Pediatric access to exoskeletons lags far behind
that of adults. In this article, we promote inclusiveness in
exoskeleton robotics by identifying and addressing chal-
lenges and barriers to pediatric access to this potentially life-
changing technology. We first present available exoskeleton
solutions for upper and lower limbs and note the variability
in the absence of these. Next, we query the possible reasons
for this variability in access, explicitly focusing on children,
who constitute a categorically vulnerable population, and
also stand to benefit significantly from the use of this
technology at this critical point in their physical and
emotional growth. We propose the use of a life-based design
approach as a way to address some of the design challenges
and offer insights toward a resolution regarding market
viability and implementation challenges. We conclude that
the development of pediatric exoskeletons that allow for and
ensure access to health-enhancing technology is a crucial
aspect of the responsible provision of health care to all
members of society. For children, the stakes are particularly
high, given that this technology, when used at a critical
phase of a child’s development, not only holds out the
possibility of improving the quality of life but also can
improve the long-term health prospects.
Keywords: pediatric exoskeletons, wearable robotics, life-
based design, children, health-care system, access, person-
alized medicine, trust
1 Introduction
Robotics have increased productivity and resource efficiency
in the industrial and retail sectors, and now there is an
emerging interest in realizing a comparable transformation
in other areas, including health care [1]. However, the
introduction of robots for health-care and therapeutic
purposes that interact directly with patients, older adults,
and children is not straightforward. It is widely recognized
that these robots can entail risks for users and could infringe
on rights and further may have a significant impact on care-
recipient values, including those of workers’ and end-users’
values [2–9].
A relatively new technology that is changing the lives of
impaired users is physical assistant robots. Physical assistant
robots, also named exoskeletons, help users perform a task
by augmenting or supplementing their capabilities (ISO
13482:2014). Exoskeletons derive their name from the fact
that they work as an external skeleton that supports the user.
First developed in the military, these robotic devices were
designed to help soldiers carry heavier weights for longer
distances. Nowadays, these robots are already deployed in
the industry, aiming to improve the conditions of workers as
well as in the health-care sector to help wheelchair users
stand up and walk or assist in the rehabilitation of persons
with neurologic or musculoskeletal problems with their
ambulatory needs [10]. One of the common characteristics
of the available exoskeleton solutions is that they have
focused mainly on adult populations. A recent review of
exoskeletons shows that companies build exoskeletons for
persons from 150 cm tall onward: the Japanese Cyberdyne
starts at 150 cm, followed by EksoBionics at 152 cm and
Indego at 155 cm [8]. By contrast, the average height of a
5-year-old in Europe is between 108 and 113 cm [9]. These
height parameters prevent shorter populations from acces-
sing the benefits of this technology.
A particularly salient gap in access is found in chil-
dren. Although advancedwearable exoskeletons are currently
available, their benefits and challenges in addressing
childhood movement disorders remain underexplored [11].
Damage to the central nervous system during early develop-
ment can lead to neuromotor disorders such as cerebral palsy
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that negatively affect the quality of life of users, including
children. However, gait rehabilitation robotic devices have
primarily focused on restoring lost function after stroke or
spinal cord injury in adult populations [12–14]. Nevertheless,
despite the clear need and multifaceted potential benefit,
smaller orthoses suitable for children are not available in
the market in any substantial variety or amount. Even the
most recent literature reviews of exoskeletons include little
reference to pediatric active orthoses [15–17], suggesting
either relative absence of product or an understudied use
of the technology in this population.
Part of the problem may lie in the current design
approach. It is often the case that robotic engineers develop
robotic devices primarily on the premise that the product
should fit as many end-users as possible. This procrustean
design choice seems legitimate from a return on investment
point of view, but it may not ultimately serve marginalized
groups of people who physically deviate from the majority of
users [8]. Failing to address the needs of a broader spectrum
of users may eventually impede the fair and effective access
to the benefits of such technologies for a population that
most needs it [18].
Avoiding the “one size fits all approach” and devising a
commercially viable design strategy that accommodates
more personalized needs of the end user may be more
beneficial for the society in the long run. To the extent that
specific populations, like children, are deprived of access to
such technologies, given the short- and long-term benefits
that they can yield, the health-care system has failed them,
even though the fault is broadly distributed throughout
the design, production, compensation, and policy pipeline.
Furthermore, at a broader level, developing solutions
for groups that may not present as an attractive market
opportunity is necessary in order to support the fair and
equitable nature of health care and health-care systems.
With the widespread national embrace of personalized
medicine in many countries around the world [19], it is
surprising and puzzling that a clear need for interven-
tions designed to make health care more accessible to
young people is not approached with greater commitment.
Pediatric exoskeletons provide a compelling example of the
rationale of personalized medicine in that a “one size fits all
approach” underserves significant segments of society. The
use of medicines that are known to work in only 40% of the
population, for example, results in a situation in which
60% of that patient population derives no benefit and may
suffer toxic side effects, nonetheless [20]. Similarly, the
absence of pediatric exoskeletons leaves children to use
ill-suited adult devices with limited positive effect, at best,
or to forego this type of therapeutic intervention altogether.
Even more indefensible are the long-term effects of not
having this type of rehabilitative intervention for children
at a time when it could improve the course of their lives in
terms of physical health, well-being, and quality of life.
This is particularly disturbing when one considers the
technical availability and feasibility of the technology, in
contrast to the commercial feasibility, that development
of this product line does not appear to offer a highly
profitable market. In the following sections, we explore
ways in which both the need for commercial viability and
the needs of this largely overlooked population could
be met.
In this article, we aim to promote inclusiveness in exo-
skeleton robotics by addressing the challenges and barriers
to pediatric access. Our contribution lies in the inter-
play between age, wearable robot technology, and access.
We explore available pediatric exoskeleton solutions in the
market and identify challenges and opportunities for
children. Concretely, we focus on differential access to health
technology and pediatric design challenges. In this sense, our
contribution suggests applying a life-based design (LBD)
which is an approach sustained by the pursuit of children’s
good life and flourishing and has its roots in the philosophy
of Wittgenstein [21], specifically Wittgenstein’s notion of form
of life can be applied in this instance because it suggests the
steering of the engineering process toward a more persona-
lized and person-centered approach addressing the needs of
children in the design approach. We conclude that the
myriad ways in which the pediatric patient group can benefit
from the use of exoskeletons, particularly at critical times in
their physical and psychological development, justifies and
even demands a more nuanced and committed approach to
the design of pediatric exoskeletons. Addressing the barriers
to pediatric access can lead to a more inclusive health-care
system.
2 Exoskeletons: a question of
access
Exoskeletons are robotic-assistive devices that originated in
the military to enable soldiers to carry heavy loads longer
and more comfortably [22]. This function convinced several
industries to adopt the technology to support those workers
who regularly handle heavy things¹ [23,24] and were
subsequently included in as an example of “physical-
assistant robots” within ISO 13482:2014 Safety Require-
ments for Personal Care Robots, which defines them as a
“personal care robot that physically assists a user in

1 See http://www.robo-mate.eu/.
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performing required tasks by providing supplementation or
augmentation of personal capabilities.”
Seeing the increasing development in the field of
exoskeleton innovation, some sectors saw in this tech-
nology a promising approach to rehabilitation and health-
care sectors, especially for patients with physical impair-
ments in either the upper or the lower limb. Several
research groups have made significant progress in in-
creasing mobility for patients who suffered a stroke or
spinal cord injury [12–14]. The primary role of a therapeutic
exoskeleton is to substitute or provide the missing function
resulting in health benefits such as improvements in gait
function, body composition, aerobic capacity, bone density,
spasticity, bowel function, and quality of life [25,26].
Enhancing users’ ability to move and walk helps them to
fulfill a primary human function that stabilizes blood
pressure, improves pulmonary ventilation, prevents the
degeneration of muscle and bone tissue, and increases joint
mobility [27].
Other research shows promising advances in hand
orthoses, for therapy or daily assistance, which are
increasingly simplified and less cumbersome [28]. These
advancements enhance hand function and reduce fatigue
while grasping and are particularly relevant for individuals
with muscular dystrophy [29]. Such health-care advances
can prolong the life expectancy of several populations with
impairments, in that complete or partial restoration of
physical abilities contributes to a persons’ ability to engage
in daily life activities and to their self-esteem, both of which
can be of vital importance to the psychological and physical
well-being of a person and hence to his or her ability to
flourish. Furthermore, exoskeletons afford much more
independence than wheelchairs in everyday environ-
ments such as in shopping malls, local parks, or movie
theaters [30].
Although exoskeletons are a powerful tool to help
restore motor functions and provide effective assistance for
those that cannot afford human caregivers, access to these
technologies is largely limited to or through hospitals or
rehabilitation centers where these expensive devices are
financed through institutional means, such as insurance
or subsidized health care. It is not yet common to see
exoskeletons in private homes, as they are usually cumber-
some and prohibitively expensive or still under develop-
ment [31,32]. Exoskeleton technologies in the open
market are only available either through purchase using
one’s resources or in the select cases where individual
health insurance covers robotic rehabilitation. This
limitation could raise social justice concerns, including
regarding equal access to health care [32]. The potential
use of exoskeletons outside of these limited settings and
circumstances points to the need to enhance access in
systematic ways.
At the crossroads between realizing an innovative idea
and the return on investment lie a very dynamic balance
in which the interests of potential users are subordinated
to commercial viability. Even inadvertent failure to provide
access to health technologies in the service of the health-
care needs of a segment of society ultimately contributes
to an unresolved ethical and social issue of health-care
inequality. As a matter of health policy, this differential
access warrants serious consideration. Just as measures
are taken to incentivize and encourage the development
of health-enhancing pharmaceuticals for all persons
who may need them, e.g., pregnant women, children, or
persons with rare diseases, the need to operationalize this
imperative for pediatric exoskeletons in the service of
children is compelling. Moreover, the standard that
regulates personal care robots (including physical-assis-
tant robots and exoskeletons, ISO 13482:2014) already
acknowledges that these populations deserve special
consideration. Nevertheless, no major steps have been
taken to realize such an imperative [4].
3 Pediatric exoskeletons
The expanding and ongoing research demonstrates the
potential for a patient’s improvement from medical,
technological, and social viewpoints. However, it is not
entirely clear how market players will efficiently imple-
ment this technology for younger populations that need to
train a different walking pattern rather than to restore the
lost walking capability [11]. When we refer to children, we
refrain from alluding to a specific age range, because age is
not a common parameter companies take into account.
Several types of exoskeletons exist globally, differing in
intended use, complexity, device weight, and device size,
i.e., to fit different femur lengths (height related or hip
width). We conducted a review of the robots, exoskeletons
for children using the databases Google scholar, PubMed,
and IEEE Explorer, using the key words “pediatric AND
exoskeleton”, “exoskeleton AND for AND children,” and
“rehabilitation AND robots AND for AND children.”
We excluded social robots that served no physical
therapeutic purpose. Since the first pediatric exoskeleton
dates from 2011 [33], our review covered the period of 2010
to 2019. We noted that many of these robots were never
brought to market. A non-systematic review of commercially
available exoskeletons revealed that main manufacturers,
significant players in the exoskeleton market such as
Rewalk,² EksoBionics,³ Indego,⁴ and Cyberdyne⁵ do not
Promoting pediatric access in exoskeleton robotics  329
currently offer any product for short femurs or small hips,
which would typically fit pediatric or short populations.
The only company on rehabilitation technology offering
pediatric solutions seems to be Hocoma. The LokomatPro
from Hocoma is one of the very few treadmills that offer
orthoses for adults or children. Treadmill-based body weight
support locomotor training has shown positive results in
children and adults with cerebral palsy. The pediatric
orthoses are designed to accommodate small children
by offering a unique set of harnesses and cuffs that provide
a precise fit for patients with femurs between 21 and
35 cm.⁶ However, Lerner, Damiano, & Bulea [11] highlight
that improvements in controlled trials were not more
significant to therapies of equal intensity, pointing out that
these treatments should not replace overground training.
However, this single example illustrates the type of lost
opportunity for improved health and well-being for children
at formative stages that the narrow offering of adult-oriented
exoskeletons creates.
Existing solutions are in some measure limited by
height, e.g., Japanese Cyberdyne starts at 150 cm, followed
by EksoBionics at 152.40 cm and Indego at 155 cm. Most
of these exoskeleton solutions follow the average human
height beginning at 62.2 inches, i.e., 157.98 cm in Indonesia
presented by World Population Review (2019). However,
some populations have an average below this, such as
Filipino females with an average height of 150 cm, which is
3 cm higher than Indonesian females, but 3 cm shorter
than females from Southeast Asia [34]. Dividing the sum of
the values by their number provides an average height
population of below 150 cm. However, this approach not
only goes against the existing ethnic and cultural differences
but also underestimates the current diversity in a society,
i.e., persons with dwarfism, youth, or children would not
benefit from these exoskeleton solutions for adults of
average height [8].
The following table includes a non-systematic review of
some of the available pediatric wearable exoskeletons (see
Table 1). There are not many commercially available models.
Atlas 2020 and 2030 from MarsiBionics have been devel-
oped, but the company is still in a crowdfunding status, not
yet mass-producing these technologies.⁷ Tréxō Robotics is a
Canadian company that has developed TrexoPlus pediatric
exoskeletons attached to a walker for home use at a cost of
nearly $30,000.⁸ Agilik technologies, also a Canadian
company, has developed ExoStep,⁹ and a tried-and-tested
exoskeleton technology developed by Bionic Power, a
military company focusing on exoskeletons,¹⁰ which is not
available for sale but rather can be licensed.
Other research centers are developing solutions to assist
children with their lower or upper limbs. One such solution
is the exoskeleton developed by Lerner, Damiano, & Bulea
that featured in Science in 2017 that focused on the
development of a lower extremity exoskeleton that improves
knee extension in children with crouch gait from cerebral
palsy [11,35]. MIT’s Pediatric AnkleBot is a lower extremity
robotic therapy module that aids the recovery of ankle
function in children with cerebral palsy [33,36]. In Italy,
some researchers also developed a solution for children with
cerebral palsy: the “Wearable Ankle Knee Exoskeleton”
or WAKE-up, which was a powered knee-ankle-foot orthosis
to assist children with their volitional movements [37].
Researchers are also working on upper limb exoskeleton
solutions. Some researchers developed ChARMin, an actu-
ated upper limb exoskeleton, to provide intensive rehabili-
tative training for children with affected arm motor function
[38]. At ETH Zurich, other researchers developed a pediatric
hand exoskeleton for grasping assistance in task-oriented
training called PEXO [39].
4 Facilitating access: Revisiting
the approach to exoskeleton
design
The preceding overview of current and developing exoske-
letons could suggest two underlying barriers to pediatric
access, first that children as a group appear to show limited
interest in a market-driven industry and, second, that the
design of pediatric exoskeleton is more challenging com-
pared to adult ones. From this overview, we also understand
that pediatric robotics entails a vast trust ecosystem




4 See http://www.indego.com/indego/en/home, in particular http://
www.indego.com/Indego/ImageDownload?staticfile=/Indego/Indego%







9 ExoStep is not yet available for sale to consumers, although they
are selling units in limited numbers for research purposes. See
https://agilik.com/product/.
10 See https://www.bionic-power.com/.
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developers, from which other barriers at the implementation
stage may arise.
4.1 Children may seem to present limited
opportunity in a market-driven industry
We speculate that purely from a market perspective, the
design and manufacture of pediatric exoskeletons may seem
less profitable than the steady and growing market of
adults. However, leaving the design, manufacture, and
production of pediatric exoskeletons completely to market
forces results in a highly significant and consequential
unmet need in that children could avoid long-term impacts
on the health and well-being by the use of various types of
exoskeletons. This is an unmet health need that society
knowingly allows persisting despite the technical feasibility
of addressing it. A purely market-driven approach would
suggest that the industry should be free to choose its target
market, particularly in developing a particular product line
that seems expensive and time-consuming [27].
Some of the current design approaches, such as in
EksoGT or EksoNR from EksoBionics,¹¹ appear to be based on
an “ableist perspective,” which assumes and grounds
the design approach based on average or common adult
abilities. Such a presumption leads to the design of pediatric
exoskeletons carrying over virtually all of the characteristics
of the adult exoskeleton only in a much smaller version.
Generally speaking, the current design methodologies tend
to be less person-centered and more technology-centered,
essentially miniaturized versions of adult exoskeletons that
demand that the child user adapt to technology. There-
fore, the design of pediatric exoskeletons shifts from a
mere engineering or commercial challenge and becomes a
moral requirement to provide children with musculoskeletal
disorders with equal opportunity for a good life and an
ability to flourish.
In the domain of assistive robotics, traditional industrial
approaches oriented primarily toward profit maximization
should not be detrimental in ensuring safety, adaptivity,
long-term autonomy of operation, user-friendliness, and low
cost [40]. The introduction of a robot in a person’s life is not a
simple, monodimensional event. On the contrary, it is a long
process that, in principle, should align with that person’s
values, wishes, and sensibilities, such as personal intimacy
[41]. These values might complement other universal values
already recognized in the design of social robots such as
autonomy, privacy, safety, enablement, independence, and
social connectedness [41]. Current literature does not address
what values could or should be translated or integrated into
pediatric exoskeletons directly, beyond standard considera-
tions of safety, user-friendliness, and autonomy enhancing.
Current regulations seem not to reflect this either [4]. The onl
y available framework concerning physical-assistant robots is
the ISO 13482:2014 which stresses the importance of such
aspects and disclaims that “future editions of this Interna-
tional Standard might include more specific requirements on
particular types of personal care robots, as well as more
numeric data for different categories of people (e.g., children,
elderly persons, pregnant women).”¹² Although the industry
recognizes the unique safety demands for specific popula-
tions, including children, not having developed standards
and guidelines covering these particular needs puts a twofold
barrier: to the safe design of these devices and their
subsequent market entrance.
4.2 Design challenges of pediatric
exoskeletons
Among the first and perhaps most formidable challenges
confronting the design of pediatric orthoses is the fact that
children, by definition, are in a growth phase during which
their bodies are changing in size and proportion. This
has a profound effect on the capacity of an exoskeleton
to serve a child’s rehabilitative needs effectively. While
the likelihood of outgrowing an exoskeleton device
might be very minimal in adult populations, as they do
not tend to grow significantly after a certain age, a child
of 4 years is likely to outgrow the exoskeleton by the age
of 6 [42]. Adaptable modules to different femur sizes
might be ideal, along with whatever other physiological
changes to what the exoskeleton should accommodate.
Moreover, the child’s preferences may also grow or change
over time. This particular design challenge is also likely
to have implications for commercial viability discussed
earlier.
Another challenge relating closely to the develop-
ment and evolution of children is the fact that children,
with the assistance of an orthosis, may learn to walk for
the first time. Before this, they might not have a strong,
fixed notion, or experiential conception of what it means
to move in this way. Other children who may have had
the experience of walking and moving freely in a natural
environment, but subsequently may have suffered an





332  Eduard Fosch-Villaronga et al.
movements that current exoskeletons provide. Therefore, in
both cases, one of the biggest challenges will be the users’
acceptance and accessibility. Different factors might influ-
ence users’ acceptance. Concerning the characteristics of the
robot, size, adaptability, functionality, perceived ease of use,
and usefulness might be necessary [43,44]. Age, stage of
physical, cognitive, and social development, specific needs,
attitudes, and personal circumstances should play an
important role also with robot-based characteristics. Func-
tionality and perceived ease of use are essential to the
development of exoskeletons in respect to age, where their
design needs to take into consideration not only the physical
body structure but also the cognitive abilities of the person,
which affect a person’s ability to understand how the
technology works as well as the ability to learn how to use it.
Similarly, age and stage of development affect both the
capacity for technological dexterity and non-tangible but
valued considerations such as social comfort. In a child-
based context, active emotional support from parents and
caregivers in the understanding of the technology is of
particular importance. Age also represents a challenge for
the research community, designers, and engineers who are
designing a product that can be effective and easier to use
[45] because of the variability in the development of
cognitive capacities and maturity. In the case of exoskeletons
for children, the challenge is even more significant because,
as noted, the design needs to be adaptable to the physical
development of children. This requirement directly opposes
the more “average-user design” preferred by industry.
Playing is the most desired activities among children.
The ability to move freely and play with other children are
generally regarded as critical to their well-being. However,
significant differences in capabilities can make this difficult
or even impossible. One critical role of the pediatric
exoskeletons is to provide children with the ability to play
with their peers and empower their sense of “being one of
them.” However, current exoskeletons are not always light-
weight, and they do not provide natural movement. Some
users have reported feeling like a “Christmas tree” due to the
multitude of sensors that adorn the user [10]. These features
may hinder a child’s sense of “blending in,” but at the same
time, make the desired interaction possible. Although
exoskeletons may have some autonomous functions, users
can usually overpower the device. This way, users tend to
remain in control and do not lose the “human-added value”
in action [31,46]. Being in control of the device may lead to a
decreased level of mistrust if the child does not trust himself
or herself to operate the device competently. Nevertheless, for
their safety, the system should be prepared for such
unpredictable behavior to react in time to prevent harm to
children.
Design for safety in exoskeletons may refer to preventing
the person from falling and avoiding other related harms
during its use. Safety, in this sense, dissociates in certified
and perceived safety, that is, a “certified robot might be
considered safe objectively, but a (non-expert) user may still
perceive it as unsafe or scary.” The latter is tightly associated
with trust, in trusting that the device will not make a user fall
[40,47]. Trust is one of the leading values in human–robot
interaction (HRI) [48–51]. A lack of trust in robotics often
relates to the technical functionality and the perception of
safety the user has. Ideally, an exoskeleton should be
reliable and trustworthy [8]. Besides safety, trust also
depends on how the designers have adequately addressed
other aspects, such as privacy, robustness, security, and data
protection [52]. Age and cultural preferences also affect trust.
For instance, there are situations where older adults were
less receptive to robots as compared to younger adults
[51,53]. Because of these multiple and multifaceted design
considerations, it is not difficult to understand how design
challenges could present a barrier, albeit surmountable, to
commercial production.
4.3 Implementation challenges:
the importance of trust
Trust in an HRI relationship also has a moral dimension. It
connects to vulnerability because the trustor is dependent
on the trustee and may not necessarily know whether the
trustee is trustworthy [51]. In the philosophical debate on
trust, trust has been analyzed as an attitude of optimism
toward others, assuming their goodwill, when we rely on
them in the face of uncertainty and risk of harm or
exploitation. Baier [54] highlights that trust is inherently
risky and makes visible the subject’s vulnerabilities: “[w]
here one depends on another’s goodwill, one is necessarily
vulnerable to the limits of that goodwill.” Trust is of
particular importance in the context of pediatric exoskele-
tons wherein the trust ecosystem might involve a child with
a specific motor or cognitive impairment, parents, care-
givers, and technology developers (including manufac-
turers or companies), and trustworthiness must be nego-
tiated among and between all of these parties [54,55].
Moreover, the relationship between trust and expectations
may complicate the trust ecosystem, as, for example, when
parents base their expectations from industry on overhyped
and unrealistic claims that appear in the media or self-
promoting advertising literature that are far from the
current technological feasibility.
Children with acquired or developmental disorders
are especially susceptible to the risks posed by overtrust
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because children cannot adequately assess the hazards of
using sophisticated technological devices [56]. Parents,
who would usually be relied upon to provide this kind of
assessment, are also often themselves very much emotion-
ally invested in the technology as a potential solution or
treatment for their child, such that they may not adequately
identify and evaluate the risks associated with the use of a
robot. Moreover, children are more likely to conform to
robots [57], and in a worst-case scenario, robot designers
and producers may exploit this “defenselessness” [58,59].
Trust and, eventually, acceptance also depend on one’s
perceptions and attitudes toward robots [60]. Negative
perceptions, such as the users perceiving technology as too
complicated and costly, may lead to non-acceptance [60,61]
and a related lack of trust. One solution to the acceptance
issue might lie in the neglected niche of the personalization
of robotics. Design that adopts a person-centered approach
might reduce device complexity for the user, increase the
ease of use, and foster positive experiences [62].
Design plays a crucial role in the personalization of the
exoskeletons for children, as it presents an opportunity to
decrease the feeling of being ostracized by the stigma of
being different. The personalization of technological artifacts
has four effects: (1) perceived ease of use, (2) recognition of
“mine” versus “others,” (3) reflection on personal identity,
and (4) feeling in control [62]. Personalization has demon-
strated positive effects in the design of different technolo-
gical devices, including mobile phones [62] and PCs or
Roomba robots [63], and provided a hopeful perspective for
socially assistive robotics (SARs) as well [61]. Personaliza-
tion is an extension of the so-called customization needs,
where robot design demonstrates an understanding of the
users’ individual needs [61,64,65]. In this way, customiza-
tion contributes to the well-being of users without restricting
their rights [65].
Personalization can contribute to the development of
the long-term trust relationship between humans and
robots, an aspect that has been recognized in the domain
of SARs [51,66–68]. As well, personalization has been
found to encourage user acceptance among adults [51,69].
This trust relationship is also crucial for children, given
their increased vulnerability as compared to adults. Pino
and colleagues argue that personalization could overcome
individual differences and provide the user with a sense
of autonomy and control over the robot, facilitating the
appropriation and embodiment of the exoskeleton as an
extension of the user’s body [61].
The question of costs and profits remains a crucial
consideration for the industry. The duty to deliver on the
bottom line requires that production be efficient and
capable of yielding a profit. Customized exoskeletons for
a dynamic population present multiple challenges for
the industry, even if they are convinced of its merit.
Strategies need to be developed that make the design and
production of pediatric exoskeletons not only effective
and safe but also attractive from a market perspective.
Among the avenues that could be pursued is the use of
emerging 3D printing technologies [70]. Already in use in
several other industries, such as housing [71], 3D printing
could provide cost-efficient means to produce parts for
personalized exoskeletons for growing pediatric popula-
tions and, at the same time, expand options for adults
who may benefit from more personalized features [72,73].
Other alternatives might include exploring the limits of
modularity in designing such that exoskeletons could be
modified rather than replaced to accommodate a growing
young body. Finally, the ability to offer an effective
therapeutic product for this vulnerable and highly
sympathetic population may meet with increased recep-
tivity from institutional customers like hospitals and
insurance providers, further enhancing its market
viability.
5 Theoretical basis for a new
design approach
Technology has always been a supportive means for people
to realize their life goals and to improve their lives by making
it more comfortable. Such technology’s impacts can also be
found in the domain of pediatric exoskeletons. However, to
develop a technology that will improve the lives of children,
we must understand what a good life means for them. A
useful answer to that inquiry can be found in the application
of the LBD framework that seeks to accommodate children’s
life context, needs, values, and acceptance of pediatric
exoskeleton. The starting point of the design process should,
therefore, be based on familiarity with the target children
population, their needs, limitations, desires (what “a good
life” means to a child and expectations of how the
exoskeleton would improve his/her life). To that end, we
find that perhaps the most suitable approach to use in the
development of pediatric exoskeletons would be an LBD
rather holistic approach in which a whole “life” becomes a
central referral point for technology implementation for
improvement of the individual well-being, introduced by
Jaana Leikas in the field of gerontechnology [74]. We
propose that the LBD approach with respect to the current
state of the art would give importance to the children’s
everyday life requirements consisting of daily activities and
leisure time.
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The LBD is not a purely theoretical approach but
a practical process consisting of four phases relying on
conceptual methodology of “unified systems of action”
(called “forms of life”). According to this approach, designers
or engineers must understand the segregated “systems of
action” among the target population; in this case, children
[75]. By understanding these “unified systems of action”
within a given domain or section of the child’s life, the new
technology can be designed to accommodate the needs of
the child in different segments or facets of his/her world.
People can participate in the unlimited number of “systems
of action,” voluntarily or involuntarily, e.g., in regards to a
hobby or other recreational activity, profession, family status,
or a situation [76].
1) The first phase in the LBD process is to recognize the
“unified systems of action” of a particular group of
children using a form-of-life analysis, which will help to
develop pediatric exoskeleton solutions. Such a pre-
design investigation will contribute to discovering the
human requirements of the technical artifact, the
reasons, and motivations that will guide the design
process of the technology that should improve human
life. The development of the pediatric orthosis is different
from the development of adult orthosis because children
will need not only much smaller orthoses that are lighter
and less robust but also flexible enough to accommodate
perhaps less predictable behavior. Additionally, the
orthosis should enable them to move by walking upright
like adults but also enable them to engage in a range of
motions necessary to play with other children [77].
Applied here, the concept of LBD becomes a tool that
identifies the differences in different life settings and
entities within children’s everyday life. Participating
in “systems of action” for different life domains,
people generally follow different rules and regularities,
e.g., child’s school day consists of waking up, getting
washed, having breakfast, going to school, taking part
in schoolwork, meeting classmates during breaks,
returning home, and doing their homework. These
represent rule-following actions that provide meaning
in their form of life, and they can also give a sense of
technological ideas in the technology design. The form
of life mostly focuses not only on the individual but on
the group of people, e.g., children [76].
To understand the rules and regularities not only
means having an adequate picture of an individual’s
“unified systems of action” for each domain but also
an understanding of facts and values, i.e., why people
pursue specific actions. In this case, children embody
many factors such as age, gender, health status, educa-
tion, and so forth that explain and determine goals of
rule-following actions and even provide limits by
restricting what they can do in their lives. Ascertaining
a child’s set of “unified systems of action” enables
understanding of that individual’s everyday context
and real needs that arise in this context [76]. The facts
and values facilitate understanding of the needs of the
people, including biological, psychological, or socio-
cultural [75]. Most of the children who require pediatric
exoskeleton are affected by different musculoskeletal
disorders, as a biological fact that practically shapes
their “unified systems of action” present alongside this
is the desire of these children to walk normally and to
run or to play with their peers. Therefore, besides facts
within the design process, attention should also be
given to the values that people follow in their life, by
providing the information necessary for analyzing and
understanding their “form of life.” The importance of
value understanding might assist in identifying the
kind of “worth” the technology might bring [76].
Knowledge of a child’s values helps develop mean-
ingful, supportive technologies in actions and things
that are valuable to them, like walking freely and
playing with their peers. Understanding of facts and
values and with them the associated rule-following
actions forms the design-relevant attributes that can
enhance the outlining of pediatric design goals [76].
2) In the second phase of the LBD process, the technology
is designed to support rule-following actions becoming
the technology-supported actions (TSAs) [76]. For
example, walking is a rule-following action, but walking
with the support of exoskeleton would be a “TSA.” In
the LBD approach, the design of every TSA should be
crafted with reference to a desired action and its goals,
the agent, the context, and possible technology. Before
designing a pediatric exoskeleton, it is then necessary to
understand the child’s need for such supportive service;
in other words, the goals of using it. To discover the
children’s goals and values can only be achieved by
including the user from the beginning of the design
process, regarding children as experts of their everyday
life, essentially involving them into co-designers [78].
This may also have the benefit of addressing some of the
implementation challenges if this early involvement in
design facilitates a greater understanding of and comfort
with the limitations of the technology.
3) The third phase of the LBD process includes fit-for-life
design. This phase inquires about the impact of the
developed solutions on the quality of life. In our case of
pediatric exoskeletons, we inquire about the outcomes
that the exoskeletons will provide and evaluate whether
they genuinely satisfy the child’s needs. This stage mostly
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refers to the previously addressed issue of acceptance
and trust, where using different survey methodologies,
various factors can be assessed, such as perceived
ease of use, usefulness, or enjoyment (attitude) toward
particular technology from the children (user) and
parent perspective [79].
4) After the evaluation of the impact, if the design of an
exoskeleton meets the children’s needs, the fourth phase
of the LBD process– innovation design– takes place. This
final phase aims to export the design outcome into
general use by incorporating the technology into human
life settings, ensuring that children use the future product
[80]. To facilitate the uptake of the technology by those
who could most benefit from it, health-care systems and
other societal institutions, in addition to the producers,
may be called upon to contribute to the appropriate
integration of this technology.
The above-structured process represents a person-
centered approach where the design of exoskeletons is not
only how to produce a functional exoskeleton, but an
exoskeleton that will improve the quality of the child’s life. In
its primary focus, the LBD design strives to understand what
the good life of a child would be and to promote it within
the design of the technological artifact. LBD applied to the
context of pediatric exoskeleton development by pro-
moting the good of the child accomplishes multiple goals:
first and foremost, it supports the child’s capacity to
flourish. Such an approach requires a morally virtuous
action from the designers and engineers, promoting and
integrating Aristotelian virtues such as phronesis in the form-
of-life analysis, or virtue of justice when the exoskeleton
adequately responds to the child needs, reducing the
prevalence of unmet needs and inequalities among their
peers. Pediatric exoskeletons will facilitate a “good life”
for children with impairment in the form of best possible
life [81], taking situation and context into consideration.
Personalized exoskeletons built with an LBD approach further
enhances the possibility for human flourishing among
children with neuromusculoskeletal disorders. It is essential
to acknowledge that although the exoskeleton will improve
the child’s quality of life, it will also modify their “form-of-
life” demanding from them the virtue of temperance (self-
restraint) in accommodating and accepting the exoskeleton
in their everyday life, especially after noting the differences
in abilities between them and their peers’ abilities.
6 Conclusion
Our primary aim with this article is to identify and
address challenges and barriers of pediatric access to
exoskeletons and promote inclusiveness by design. In the
field of exoskeleton development, children and their needs
appear to be substantially overlooked, with some few excep-
tions presented in our overview. We identify three reasons
for this paucity of pediatric products: (1) a lack of market
appeal because of the investment or costs associated with
product development for such a complex target population,
(2) design challenges for pediatric exoskeletons in compar-
ison to the design for adults. This is due in part to children’s
physical growth and the variability of learning abilities.
Finally, we attribute this phenomenon also to (3) imple-
mentation challenges related to trust.
We conclude that the unmet health needs of the
pediatric patient group who would benefit in a myriad of
ways from the use of exoskeletons, justify and demand a
more nuanced approach to the design of pediatric
exoskeletons. We suggest that design approaches must
balance market realities with the health and life needs of
this segment of the population. The neglect of children’s
needs and the failure to provide adequate technological
solutions represent a major barrier to accessing the
benefits that the technological advances bring about.
Both as a matter of policy and moral commitment to the
well-being of all members of society, we propose the
application of the LBD in pediatric exoskeleton design.
Promotion of inclusivity and, specifically, pediatric access
using a variety of institutional and policy mechanisms
will further our collective well-being by contributing to
more inclusive health care.
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